BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

826 related articles for article (PubMed ID: 29643130)

  • 21. Transcatheter aortic valve replacement- management of patients with significant coronary artery disease undergoing aortic valve interventions: surgical compared to catheter-based approaches in hybrid procedures.
    Baumbach H; Schairer ER; Wachter K; Rustenbach C; Ahad S; Stan A; Hill S; Bramlage P; Franke UFW; Schäufele T
    BMC Cardiovasc Disord; 2019 May; 19(1):108. PubMed ID: 31088373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of transcatheter aortic valve replacement in California: Influence on aortic valve surgery.
    Maximus S; Milliken JC; Danielsen B; Shemin R; Khan J; Carey JS
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1447-1456. PubMed ID: 29554785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Comparative Study of TAVR versus SAVR in Moderate and High-Risk Surgical Patients: Hospital Outcome and Midterm Results.
    Abdelgawad AME; Hussein MA; Naeim H; Abuelatta R; Alghamdy S
    Heart Surg Forum; 2019 Aug; 22(5):E331-E339. PubMed ID: 31596707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complications After Self-expanding Transcatheter or Surgical Aortic Valve Replacement.
    Conte JV; Hermiller J; Resar JR; Deeb GM; Gleason TG; Adams DH; Popma JJ; Yakubov SJ; Watson D; Guo J; Zorn GL; Reardon MJ
    Semin Thorac Cardiovasc Surg; 2017 Autumn; 29(3):321-330. PubMed ID: 29195573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in Isolated Surgical Aortic Valve Replacement According to Hospital-Based Transcatheter Aortic Valve Replacement Volumes.
    Kundi H; Strom JB; Valsdottir LR; Elmariah S; Popma JJ; Shen C; Yeh RW
    JACC Cardiovasc Interv; 2018 Nov; 11(21):2148-2156. PubMed ID: 30343022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in volume and risk profiles of patients undergoing isolated surgical and transcatheter aortic valve replacement.
    Mori M; Bin Mahmood SU; Geirsson A; Yun JJ; Cleman MW; Forrest JK; Mangi AA
    Catheter Cardiovasc Interv; 2019 May; 93(6):E337-E342. PubMed ID: 30269424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcatheter versus surgical aortic valve replacement in patients at low surgical risk: A meta-analysis of randomized trials and propensity score matched observational studies.
    Witberg G; Lador A; Yahav D; Kornowski R
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):408-416. PubMed ID: 29388308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of mitral stenosis on outcomes of aortic valve stenosis patient undergoing surgical aortic valve replacement or transcatheter aortic valve replacement.
    Al-Khadra Y; Darmoch F; Baibars M; Kaki A; Fanari Z; Alraies MC
    J Interv Cardiol; 2018 Oct; 31(5):655-660. PubMed ID: 29774601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contemporary trends and outcomes in aortic valve replacement in patients with end-stage liver disease.
    Khan MZ; Khan MU; Munir MB; Khan SU; Osman M; Balla S
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):947-955. PubMed ID: 32129573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization and outcomes of transcatheter aortic valve replacement in the United States shortly after device approval.
    Young MN; Elmariah S; Kennedy KF; Inglessis I; Yeh RW
    Catheter Cardiovasc Interv; 2017 Nov; 90(5):830-838. PubMed ID: 28326675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utilization and 1-Year Mortality for Transcatheter Aortic Valve Replacement and Surgical Aortic Valve Replacement in New York Patients With Aortic Stenosis: 2011 to 2012.
    Hannan EL; Samadashvili Z; Stamato NJ; Lahey SJ; Wechsler A; Jordan D; Sundt TM; Gold JP; Ruiz CE; Ashraf MH; Smith CR
    JACC Cardiovasc Interv; 2016 Mar; 9(6):578-85. PubMed ID: 27013157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost and contribution margin of transcatheter versus surgical aortic valve replacement.
    McCarthy FH; Savino DC; Brown CR; Bavaria JE; Kini V; Spragan DD; Dibble TR; Herrmann HC; Anwaruddin S; Giri J; Szeto WY; Groeneveld PW; Desai ND
    J Thorac Cardiovasc Surg; 2017 Dec; 154(6):1872-1880.e1. PubMed ID: 28712581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship Between Hospital Surgical Aortic Valve Replacement Volume and Transcatheter Aortic Valve Replacement Outcomes.
    Hirji SA; McCarthy E; Kim D; McGurk S; Ejiofor J; Ramirez-Del Val F; Kolkailah AA; Rosner B; Shook D; Nyman C; Berry N; Sobieszczyk P; Pelletier M; Shah P; O'Gara P; Kaneko T
    JACC Cardiovasc Interv; 2020 Feb; 13(3):335-343. PubMed ID: 32029250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Transcatheter Aortic Valve Replacement on Risk Profiles of Surgical Aortic Valve Replacement Patients.
    Craig P; Rogers T; Zou Q; Torguson R; Okubagzi PG; Ehsan A; Goncalves J; Hahn C; Bilfinger T; Buchanan S; Garrett R; Thourani VH; Corso P; Shults C; Waksman R
    Cardiovasc Revasc Med; 2020 Aug; 21(8):959-963. PubMed ID: 32387217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conventional surgery, sutureless valves, and transapical aortic valve replacement: what is the best option for patients with aortic valve stenosis? A multicenter, propensity-matched analysis.
    D'Onofrio A; Rizzoli G; Messina A; Alfieri O; Lorusso R; Salizzoni S; Glauber M; Di Bartolomeo R; Besola L; Rinaldi M; Troise G; Gerosa G
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1065-70; discussion 1070-1. PubMed ID: 24021955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcatheter ViV Versus Redo Surgical AVR for the Management of Failed Biological Prosthesis: Early and Late Outcomes in a Propensity-Matched Cohort.
    Tam DY; Dharma C; Rocha RV; Ouzounian M; Wijeysundera HC; Austin PC; Chikwe J; Gaudino M; Fremes SE
    JACC Cardiovasc Interv; 2020 Mar; 13(6):765-774. PubMed ID: 31954671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of intermediate-risk patients treated with transcatheter and surgical aortic valve replacement in the Veterans Affairs Healthcare System: A single center 20-year experience.
    Garcia S; Kelly R; Mbai M; Gurevich S; Oestreich B; Yannopoulos D; Adabag S
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):390-398. PubMed ID: 29316204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Choice of Treatment for Aortic Valve Stenosis in the Era of Transcatheter Aortic Valve Replacement in Eastern Denmark (2005 to 2015).
    De Backer O; Luk NH; Olsen NT; Olsen PS; Søndergaard L
    JACC Cardiovasc Interv; 2016 Jun; 9(11):1152-8. PubMed ID: 27209252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mid-term outcomes of Sapien 3 versus Perimount Magna Ease for treatment of severe aortic stenosis.
    Virtanen MPO; Eskola M; Savontaus M; Juvonen T; Niemelä M; Laakso T; Husso A; Jalava MP; Tauriainen T; Ahvenvaara T; Maaranen P; Kinnunen EM; Dahlbacka S; Laine M; Mäkikallio T; Valtola A; Raivio P; Rosato S; D'Errigo P; Vento A; Airaksinen J; Biancari F
    J Cardiothorac Surg; 2020 Jun; 15(1):157. PubMed ID: 32600369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Cardiac Surgery in the Randomized PARTNER 2A Trial.
    Chen S; Redfors B; Ben-Yehuda O; Crowley A; Greason KL; Alu MC; Finn MT; Vahl TP; Nazif T; Thourani VH; Suri RM; Svensson L; Webb JG; Kodali SK; Leon MB
    JACC Cardiovasc Interv; 2018 Nov; 11(21):2207-2216. PubMed ID: 30409278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.